Role of Quinones in Toxicology
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Quinones represent a class of toxicological intermediates which can create a variety of hazardous effects in vivo, including acute cytotoxicity, immunotoxicity, and carcinogenesis. The mechanisms by which quinones cause these effects can be quite complex. Quinones are Michael acceptors, and cellular damage can occur through alkylation of crucial cellular proteins and/or DNA. Alternatively, quinones are highly redox active molecules which can redox cycle with their semiquinone radicals, leading to formation of reactive oxygen species (ROS), including superoxide, hydrogen peroxide, and ultimately the hydroxyl radical. Production of ROS can cause severe oxidative stress within cells through the formation of oxidized cellular macromolecules, including lipids, proteins, and DNA. Formation of oxidatively damaged bases such as 8-oxodeoxyguanosine has been associated with aging and carcinogenesis. Furthermore, ROS can activate a number of signaling pathways, including protein kinase C and RAS. This review explores the varied cytotoxic effects of quinones using specific examples, including quinones produced from benzene, polycyclic aromatic hydrocarbons, estrogens, and catecholamines. The evidence strongly suggests that the numerous mechanisms of quinone toxicity (i.e., alkylation vs oxidative stress) can be correlated with the known pathology of the parent compound(s).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While it is not that easy to disentangle the complex reactions of ROSs with biomolecules [43,1055], at least the following appear to be a result of reactions involving OH• [2294,2295]: 8-oxo-2'-deoxyguanosine (oxo8dG) [98,2296,2297], 8-oxo-7,8- dihydro-2'-deoxyguanosine [90,92] and thymine glycol [92,2294].”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2296]
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Lipid peroxidation—DNA damage by malondialdehyde
Marnett, L. J. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00010-x · Cited by 1,304
Gelboin, H. V. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.4.1107 · Cited by 1,280
Lipid hydroperoxide generation, turnover, and effector action in biological systems
Girotti, A. W. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32182-9 · Cited by 1,200
Postmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,184
Casarett & Doull's Toxicology: The Basic Science of Poisons
Klaassen, C. D. (1998) · Cited by 1,179
Molecular mechanisms of quinone cytotoxicity
O'Brien, P. J. (1991) · Chemico-Biological Interactions · doi:10.1016/0009-2797(91)90029-7 · Cited by 1,029
Quinone chemistry and toxicity
Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., & Graham, D. G. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90273-u · Cited by 764
Self-citationSchapira, A. H. V., Mann, V. M., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
Molecular Mechanisms of Estrogen Carcinogenesis
Yager, J. D., & Leihr, J. G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001223 · Cited by 654
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Sofic, E., Lange, K. W., Jellinger, K., & Riederer, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90355-b · Cited by 590
Dringen, R., Pfeiffer, B., & Hamprecht, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00562.1999 · Cited by 589
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Implication of Mitochondrial Hydrogen Peroxide Generation in Ceramide-induced Apoptosis
Quillet-Mary, A., Jaffrézou, J.-P., Mansat, V., Bordier, C., Naval, J., & Laurent, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21388 · Cited by 476
Penning, T. M., Burczynski, M. E., Hung, C.-F., McCoull, K. D., Palackal, N. T., & Tsuruda, L. S. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980143n · Cited by 455
Self-citationRelationship Between Estrogen Levels, Use of Hormone Replacement Therapy, and Breast Cancer
Colditz, G. A. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.814 · Cited by 399
Rinsky, R. A., Young, R. J., & Smith, A. B. (1981) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700020305 · Cited by 382
Carcinogenicity of catechol estrogens in Syrian hamsters
Liehr, J. G., Wan-Fen, F., Sirbasku, D. A., & Ari-Ulubelen, A. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90080-4 · Cited by 356
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
Pearce, R. K. B., Owen, A., Daniel, S., Jenner, P., & Marsden, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350
Transport of cystine and cysteine in mammalian cells
Bannai, S. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(84)90014-5 · Cited by 329
Parkinson's disease, pesticides, and glutathione transferase polymorphisms
Menegon, A., Board, P. G., Blackburn, A. C., Mellick, G. D., & Couteur, D. G. L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03453-9 · Cited by 314
MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease
Gerlach, M., Riederer, P., Przuntek, H., & Youdim, M. B. H. (1991) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(91)90073-q · Cited by 307
Metabolism and reactions of quinoid anticancer agents
Powis, G. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90105-7 · Cited by 270
Imaida, K., Fukushima, S., Shirai, T., Ohtani, M., Nakanishi, K., & Ito, N. (1983) · Carcinogenesis · doi:10.1093/carcin/4.7.895 · Cited by 264
Puisieux, A., Lim, S.-K., Groopman, J. D., & Öztürk, M. (1991) · PubMed · Cited by 259
Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain
Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W., & Di Monte, D. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02134.x · Cited by 241
Nitric Oxide Sensitivity of the Aconitases
Gardner, P. R., Costantino, G., Szabó, C., & Salzman, A. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25071 · Cited by 237
An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure
EASTMOND, D. (1987) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(87)90196-7 · Cited by 232
Penning, T. M., Ohnishi, S. T., Ohnishi, T., & Harvey, R. G. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950055s · Cited by 232
Self-citationEvidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice
Sriram, K., Pai, K. S., Boyd, M. R., & Ravindranath, V. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01271-1 · Cited by 226
Wilhelm, D., Bender, K., Knebel, A., & Angel, P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4792 · Cited by 221
Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1
Collins, T., Williams, A., Johnston, G. I., Kim, J., Eddy, R., Shows, T., Gimbrone, M. A., & Bevilacqua, M. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52267-5 · Cited by 190
Khanna, M., Qin, K.-N., Wang, R. W., & Cheng, K.-C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.20162 · Cited by 174
Covalent and Noncovalent Interactions in Acute Lethal Cell Injury Caused by Chemicals
Nelson, S. D., & Pearson, P. G. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.001125 · Cited by 164
Fornstedt, B., Brun, A., Rosengren, E., & Carlsson, A. (1989) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02263482 · Cited by 161
Haskell, S. G., Richardson, E. D., & Horwitz, R. I. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00169-8 · Cited by 158
Sheehan, J. P., Swerdlow, R. H., Parker, W. D., Miller, S. W., Davis, R. E., & Tuttle, J. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031221.x · Cited by 150
Cloning and sequencing of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase
Pawlowski, J. E., Huizinga, M., & Penning, T. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31521-7 · Cited by 146
Self-citationMacLusky, N. J., Naftolin, F. N., Krey, L. C., & Franks, S. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90265-x · Cited by 136
Burczynski, M. E., Harvey, R. G., & Penning, T. M. (1998) · Biochemistry · doi:10.1021/bi972725u · Cited by 134
Self-citationSmithgall, T. E., Harvey, R. G., & Penning, T. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84546-5 · Cited by 133
Self-citationInteraction of Peroxynitrite with Mitochondrial Cytochrome Oxidase
Sharpe, M. A., & Cooper, C. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30961 · Cited by 133
Ceramide induces apoptosis via CPP32 activation
Mizushima, N., Koike, R., Kohsaka, H., Kushi, Y., Handa, S., Yagita∥, H., & Miyasaka, N. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)01050-2 · Cited by 133
Smith, T. S., & Bennett, J. P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00429-0 · Cited by 130
Zängerle, L., Cuénod, M., Winterhalter, K. H., & Kim, Q. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08889.x · Cited by 122
Keyer, K., & Imlay, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27652 · Cited by 119
McCann, S. J., Pond, S. M., James, K. M., & Couteur, D. G. L. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00179-2 · Cited by 115
Biochemical studies on the metabolic activation of halogenated alkanes.
Cheeseman, K., Albano, E., Tomasi, A., & Slater, T. F. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.856485 · Cited by 115
Flowers-Geary, L., Bleczinski, W. F., Harvey, R. G., & Penning, T. M. (1996) · Chemico-Biological Interactions · doi:10.1016/0009-2797(95)03660-1 · Cited by 114
Self-citationKerry, N. L., & Rice-Evans, C. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730247.x · Cited by 113
Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells.
Nutter, L. M., Ngo, E. O., & Abul‐Hajj, Y. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55309-6 · Cited by 112
THE PHARMACOLOGY AND TOXICOLOGY OF POLYPHENOLIC-GLUTATHIONE CONJUGATES
Monks, T. J., & Lau, S. S. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.229 · Cited by 112
Self-citationAromatic Hydroxylation of Estrogens
Fishman, J. (1983) · Annual Review of Physiology · doi:10.1146/annurev.ph.45.030183.000425 · Cited by 111
Hara, A., Matsuura, K., Tamada, Y., Sato, K., Miyabe, Y., Deyashiki, Y., & ISHIDA, N. (1996) · Biochemical Journal · doi:10.1042/bj3130373 · Cited by 109
Bai, F., Lau, S. S., & Monks, T. J. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990084t · Cited by 109
Self-citationSkin tumor initiating ability of benzo(a)pyrene 4,5- 7,8- and 7,8-diol-9,10-epoxides and 7,8-diol
Slaga, T. J., Viaje, A., Berry, D. L., Bracken, W. M., Buty, S. G., & Scribner, J. D. (1976) · Cancer Letters · doi:10.1016/s0304-3835(76)80020-1 · Cited by 107
Breast Cancer Risk and Duration of Estrogen Use
STEINBERG, K. K., Smith, S. J., Thacker, S. B., & Stroup, D. F. (1994) · Epidemiology · doi:10.1097/00001648-199407000-00007 · Cited by 98
Rollema, H., Damsma, G., Horn, A. S., Vries, J. B. D., & Westerink, B. H. C. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90071-3 · Cited by 98
Zumoff, B. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44202 · Cited by 93
Miller, R. T., Lau, S. S., & Monks, T. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00044-7 · Cited by 93
Self-citationDihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism
Penning, T. M. (1993) · Chemico-Biological Interactions · doi:10.1016/0009-2797(93)03203-7 · Cited by 92
Self-citationActivated microglia cause superoxide-mediated release of iron from ferritin
Yoshida, T., Tanaka, Μ., Sotomatsu, A., & Hirai, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11490-n · Cited by 85
Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration
Toffa, S., Kunikowska, G., Zeng, B. ‐., Jenner, P. G., & MARSDEN, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01271295 · Cited by 83
Stone, D. M., Johnson, M., Hanson, G. R., & Gibb, J. W. (1989) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(89)90048-5 · Cited by 80
Neurodegeneration and Neuroprotection in Parkinson's Disease
(1996) · Elsevier eBooks · doi:10.1016/b978-0-12-525445-8.x5000-0 · Cited by 80
Li, Y., Kuppusamy, P., Zweier, J. L., & Trush, M. A. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03326-4 · Cited by 74
Self-citationPawlowski, J. E., & Penning, T. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36860-6 · Cited by 73
Self-citationSpink, D. C., Spink, B. C., Cao, J. Q., Gierthy, J. F., Hayes, C. L., Li, Y., & Sutter, T. R. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00024-1 · Cited by 73
Ross, D., Siegel, D. M., Schattenberg, D. G., Sun, X. M., & Moran, J. L. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.961041177 · Cited by 73
Carboni, S., Melis, F., Pani, L., Hadjiconstantinou, M., & Rossetti, Z. L. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90131-r · Cited by 72
Kostrzewa, R. M. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-477-1 · Cited by 72
Murty, V. S., & Penning, T. M. (1992) · Chemico-Biological Interactions · doi:10.1016/0009-2797(92)90077-x · Cited by 70
Self-citationTumour-initiating activities on mouse skin of dihydrodiols derived from benzo[a]pyrene
CHOUROULINKOV, I., Gentil, A., Grover, P. L., & Sims, P. H. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.207 · Cited by 70
Mitochondrial Dysfunction in Neurodegeneration
Cooper, J. A. D., & Schapira, A. H. V. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022642114734 · Cited by 68
Highly selective neurotoxins : basic and clinical applications
Kostrzewa, R. M. (1998) · Humana Press eBooks · Cited by 58
Zhao, Z., Castagnoli, N. J., Ricaurte, G. A., Steele, T., & Martello, M. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00025a015 · Cited by 55
Relative rates of 2‐ and 4‐hydroxyestrogen synthesis are dependent on both substrate and tissue
Purdy, R. H., Moore, P. H., Williams, M. C., Goldzieher, J. W., & Paul, S. M. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80390-6 · Cited by 51
Glutathione in the Nervous System
(2018) · CRC Press eBooks · doi:10.1201/9780203753088 · Cited by 51
Inoue, M., Saito, Y., Hirata, E., Morino, Y., & Nagase, S. (1987) · Journal of Protein Chemistry · doi:10.1007/bf00250285 · Cited by 48
Smithgall, T. E., Harvey, R. G., & Penning, T. M. (1988) · PubMed · Cited by 46
Self-citationButterworth, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.3.561 · Cited by 39
Hormone-Replacement Therapy — Breast versus Heart versus Bone
Davidson, N. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322409 · Cited by 36
Tamano, S., Fukushima, S., Shirai, T., Hirose, M., & Ito, N. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90054-1 · Cited by 35
Deyashiki, Y., Tamada, Y., Miyabe, Y., Nakanishi, M., Matsuura, K., & Hara, A. (1995) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124904 · Cited by 32
Li, Y., Kuppusamy, P., Zweir, J. L., & Trush, M. A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08727-9 · Cited by 30
Self-citationLi, Y., Lafuente, A., & Trush, M. A. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00626-1 · Cited by 29
Self-citationRose, S., Hindmarsh, J. G., & Jenner, P. G. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050172 · Cited by 22
Chiueh, C. C., & HUANG, S. ‐. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb36507.x · Cited by 21
Li, Y., Kuppusamy, P., Zweier, J. L., & Trush, M. A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08726-7 · Cited by 20
Self-citation(1996) · Springer eBooks · doi:10.1007/978-1-4612-2332-0 · Cited by 20
Matarredona, E. R., Santiago, M., Machado, A., & Cano, J. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701216 · Cited by 18
If you don't have a Defibrillator
Bartecchi, C. E. (1998) · Scientific American · doi:10.1038/scientificamerican0698-91 · Cited by 1
Research works printed but not linked: 203
- Miller E. C., 1978, Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res. 38, 1479−1496
- Cavalieri E. L., 1995, Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25, 677−688
- Marnett L. J., 1995, Biochem. Soc. Symp. 61
- Aust S. D., 1993, Contemporary issues in toxicology: Free radicals in toxicology. Toxicol. Appl. Pharmacol. 120, 168−178
- Palmer H. J., 1997, Nutr. Rev., 55
- Shigenaga M. K., 1991, Assays for 8-hydroxy-2‘-deoxyguanosine: A biomarker of in vivo oxidative DNA damage. Free Radical Biol. Med. 10, 211−216
- Schlosser M. J., 1989, Metabolic activation of hydroquinone by macrophage peroxidase. Chem.-Biol. Interact. 72, 191−207
- Robertson M. L., 1991, Two benzene metabolites, catechol and hydroquinone, produce a synergistic induction of micronuclei and toxicity in cultured human lymphocytes. Mutat. Res. 249, 201−209
- Levay G., 1991, Detection of DNA adducts in HL-60 cells treated with hyroquinone and p-benzoquinone by 32P-postlabeling. Carcinogenesis 12, 1181−1186
- Bolton J. L., 1998, Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 11, 1113−1127
- Monks T. J., 1997, Biological reactivity of polyphenolic glutathione conjugates. Chem. Res. Toxicol. 10, 1296−1313
- Wallace L., 1996, Environmental exposure to benzene: An update. Environ. Health Perspect. 104 (Suppl. 6), 1129−1136
- Greenburg L., 1996, Results of medical examination and clinical tests made to discover early signs of benzol poisoning in exposed workers. Environ. Health Perspect. 104 (Suppl. 6), 1129−1136
- Aksoy M., 1971, Br. J. Ind. Med., 28
- Infante P. F., 1977, Lancet, 2, 78
- Fiserova-Beregerova V., 1995, Advances in occupational medicine and rehabilitation: Update on benzene
- Snyder R., 1996, An overview of benzene metabolism. Environ. Health Perspect. 104 (Suppl. 6), 1165−1171
- Seaton M. J., 1994, Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis 15, 1799−1806
- Valentine J. L., 1996, Reduction in benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 141, 205−213
- Twerdok L. E., 1992, Induction of quinone reductase and glutathione in bone marrow stromal cells by 1,2-dithiole-3-thione: efect on hydroquinone-induced cytotoxicity. Toxicol. Appl. Pharmacol. 112, 273−281
- Creek M. R., 1997, Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice. Carcinogenesis 18, 2421−2427
- Smith M. T., 1996, The mechanism of benzene-induced leukemia: A hypothesis and speculation on the causes of leukemia. Environ. Health Perspec. 104 (Suppl. 6), 1219−1225
- He H., 1999, Phorbol ester-induced mononuclear cell differentiation is blocked by the mitogen-activated protein kinase (MEK) inhibitor PD98059. Cell Growth Differ. 10, 307−315
- Li Y., 1999, Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen production. Biochem. Biophys. Res. Commun. 253, 295−299
- Li Y., 1993, DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation. Carcinogenesis 14, 1303−1311
- Rothman N., 1997, Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 57, 2839−2842
- Morgan J. L., 1999, Proc. Natl. Acad. Sci. U.S.A. 96
- Smith M. T., 1999, Proc. Natl. Acad. Sci. U.S.A. 96
- Trush M. A., 1996, Analysis of target cell susceptibility as a basis for the development of a chemoprotective strategy against benzene-induced hematotoxicities. Environ. Health Perspect. 104 (Suppl. 6), 1227−1234
- Kensler T. W., 1999, Development of cancer chemopreventive agents: oltipraz as a paradigm. Chem. Res. Toxicol. 12, 113−126
- Primiano T., 1998, Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: implications for chemoprevention. Carcinogenesis 19, 999−1005
- Conney A. H., 1982, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 42, 4875−4917
- Slaga T. J., 1977, Comparison of the tumor-initiating activities of benzo[a]pyrene arene oxides and diol-epoxides. Cancer Res. 37, 4130−4133
- Kim K. B., 1997, Cancer Lett., 113
- Leadon S. A., 1988, Proc. Natl. Acad. Sci. U.S.A. 85
- Chakravarti D., 1995, Proc. Natl. Acad. Sci. U.S.A. 92
- Denissenko M. F., 1996, Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274, 430−432
- Sagher D., 1983, Insertion of nucleotides opposite apurinic/apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis: uniqueness of adenine nucleotides. Biochemistry 22, 4518−4526
- Jez J. M., 1997, A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 54, 639−647
- Burczynski M. E., 1999, J. Polycyclic Aromatic Compd. (in press).
- Smithgall T. E., 1988, J. Biol. Chem., 263
- Flowers-Geary L., 1995, Identification of benzo[a]pyrene-7,8-dione as an authentic metabolite of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in isolated rat hepatocytes. Carcinogenesis 16, 2707−2715
- Tsuruda L., 1999, J. Polycyclic Aromatic Compd. (in press).
- Murty V. S., 1992, Characterization of mercapturic acid and glutathionyl conjugates of benzo[a]pyrene-7,8-dione by two-dimensional NMR. Bioconjugate Chem. 3, 218−224
- Flowers-Geary L., 1993, Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells. Chem. Res. Toxicol. 6, 252−260
- Flowers L., 1996, Disposition and biological activity of benzo[a]pyrene-7,8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase. Biochemistry 35, 13664−13672
- Shou M., 1993, Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 14, 475−482
- McCoull K. D., 1999, Synthesis and characterization of polycyclic aromatic hydrocarbon o-quinone depurinating N7-guanine adducts. Chem. Res. Toxicol. 12, 237−246
- Flowers L., 1997, Cu(II), Cu(I) redox cycling, and o-semiquinone anion radicals. Biochemistry 36, 8640−8648.
- Breen A. P., 1995, Reactions of oxyl radicals with DNA. Free Radical Biol. Med. 18, 1033−1077
- Cerutti P. A., 1985, Prooxidant states and tumor promotion. Science 227, 375−381
- Henderson B. E., 1988, Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 48, 246−253
- Liehr J. G., 1990, Genotoxic effects of estrogens. Mutat. Res. 238, 269−276
- Feigelson H. S., 1996, Estrogens and breast cancer. Carcinogenesis 17, 2279−2284
- Service R. F., 1998, New role for estrogen in cancer? Science 279, 1631−1633
- Zhu B. T., 1998, Carcinogenesis, 19, 27
- Roy D., 1999, DNA damage and mutations. Mutat. Res. 424, 107−115.
- Liehr J. G., 1983, 2-Fluoroestradiol. Separation of Estrogenicity from Carcinogenicity. Mol. Pharmacol. 23, 278−281
- Li J. J., 1984, Estrogen-induced tumorigenesis in hamsters: Roles for hormonal and carcinogenic activities. Arch. Toxicol. 55, 110−118
- Vassilopoulou-Sellin R., 1993, Estrogen replacement therapy in women at increased risk for breast cancer. Breast Cancer Res. Treat. 28, 167−177
- Lupulescu A., 1995, Estrogen Use and Cancer Incidence: A Review. Cancer Invest. 13, 287−295
- Wickelgren I., 1997, Estrogen: A new weapon against Alzheimer's. Science 276, 676−677
- Henderson V. W., 1997, S27−S35.
- Paganinihill A., 1995, Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38, 223−242
- Grady D., 1995, Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol. 85, 304−313
- Kerlan V., 1992, Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem. Pharmacol. 44, 1745−1756
- Suchar L. A., 1996, Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17β-estradiol by liver microsomes from female rats. Endocrinology 137, 663−676
- Spink D. C., 1998, Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19, 291−298
- Shimada T., 1999, Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20, 1607−1614
- Li J. J., 1987, Fed. Proc. 46
- Li S. A., 1985, Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Res. 45, 181−185
- Sarabia S. F., 1997, Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens. Chem. Res. Toxicol. 10, 767−771
- Zhang F., 1999, The major metabolite of equilin, 4-hydroxyequilin autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone. Chem. Res. Toxicol. 12, 204−213
- Yager J. D., 1996, Annu. Rev. Pharmacol. Toxicol., 36, 10.1146/annurev.pa.36.040196.001223 · DOI · Paper page
- Iverson S. L., 1996, Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem. Res. Toxicol. 9, 492−499
- Shen L., 1997, Bioreductive activation of catechol estrogen-ortho-quinones: Aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18, 1093−1101
- Penning T. M., 1993, Chem.-Biol. Interact., 89, 34, 10.1016/0009-2797(93)03203-7 · DOI
- Malins D. C., 1996, Proc. Natl. Acad. Sci. U.S.A. 93
- Shigenaga M. K., 1991, Assays for 8-hydroxy-2‘-deoxyguanosine: A biomarker of in vivo oxidative DNA damage. Free Radical Biol. Med. 10, 211−216
- Floyd R. A., 1990, The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11, 1447−1450
- Han X., 1994, 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol. Role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 54, 5515−5517
- Nutter L. M., 1994, Chem. Res. Toxicol., 7, 28
- Li J. J., 1993, Estrogen carcinogenesis in the hamster kidney: role of cytotoxicity and cell proliferation. Environ. Health Perspect. 5, 259−264
- Banerjee S. K., 1994, Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. Mutat. Res. 311, 191−197
- Chen Y., 1998, The equine estrogen metabolite 4-hydroxyequilenin causes DNA single strand breaks and oxidation of DNA bases in vitro. Chem. Res. Toxicol. 11, 1105−1111
- Chen Y., 2000, GADD153 expression and apoptosis in breast cancer cell lines. Chem. Res. Toxicol. (submitted for publication).
- Han X., 1995, Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 16, 2571−2574
- Liehr J. G., 1986, Proc. Natl. Acad. Sci. U.S.A. 83
- Liehr J. G., 1987, Localization of estrogen-induced DNA adducts and cytochrome P450 activity at the site of renal carcinogenesis in the hamster kidney. Cancer Res. 47, 2156−2159
- Abul-Hajj Y. J., 1995, J. Am. Chem. Soc., 117
- Stack D. E., 1996, Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9, 851−859
- Loeb L. A., 1986, Annu. Rev. Genet., 20
- Cavalieri E. L., 1997, Proc. Natl. Acad. Sci. U.S.A. 94
- Shen L., 1997, J. Am. Chem. Soc., 119
- Shen L., 1998, Chem. Res. Toxicol., 11, 101
- Ricaurte G., 1985, Hallucinogenic amphetamine selectively destroys serotonin nerve terminals. Science 229, 986−988
- Commins D. L., 1987, J. Pharmacol. Exp. Ther., 241
- Henry J. A., 1992, Toxicity and deaths from 3,4-methylenedioxymethamphetamine. Lancet 340, 384−387
- Stone D. M., 1986, Eur. J. Pharmacol., 128, 48
- Stone D. M., 1987, Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26, 1677−1683
- Battaglia G., 1987, J. Pharmacol. Exp. Ther., 242
- Lew R., 1996, J. Pharmacol. Exp. Ther., 276
- Bolla K. I., 1998, Memory impairmant in abstinent MDMA (“ecstasy”) users. Neurology 51, 1532−1537
- McCann U. D., 1999, Cognitive performance in (±)-3,4-methylenedioxyamphetamine (MDMA, “ecstasy”) users: a control study. Psychopharmacology 143, 147−425
- McCann U. D., 1998, Positron emission tomographic evidence of toxic effects of MDMA (“ecstasy”) on brain serotonin neurons in human beings. Lancet 352, 1433−1437
- Ricuarte G. A., 1988, Toxic effects of MDMA on central serotonergic neurons in primate: importance of route and frequency of drug administration. Brain Res. 446, 165−168
- Molliver M. E., 1986, Soc. Neurosci. Abstr., 12, 1234
- Schmidt C. J., 1988, Eur. J. Pharmacol., 156
- Paris J. M., 1992, Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain. Res. Bull. 28, 115−119
- Gollamudi R., 1989, Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Neurotoxicology 10, 455−466
- McCann U. A., 1991, Major metabolites of 3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons. Brain Res. 545, 279−282
- Midha K. K., 1978, α-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey. Drug Metab. Dispos. 6, 623−630
- Lim H. K., 1988, vivo and in vitro metabolism of 3,4-methylenedioxymethamphetamine in the rat: identification of metabolites using an ion trap detector. Chem. Res. Toxicol. 1, 370−378
- Hiramatsu M., 1990, J. Pharmacol. Exp. Ther., 254
- Patel N., 1991, Transformation of dopamine and α-methyldopamine by NG-108-15 cells: formation of thiol adducts. Chem. Res. Toxicol. 4, 421−426
- Miller R. T., 1995, Metabolism of 5-(Glutathion-S-yl)-α-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats. Chem. Res. Toxicol. 8, 634−641
- Tunek A., 1981, Toxic effects of benzene and benzene metabolites on granulopoietic stem cells and bone marrow cellularity in mice. Toxicol. Appl. Pharmacol. 59, 149−156
- Yin S. N., 1987, Br. J. Ind. Med., 44
- Snyder R., 1993, Studies on the mechanism of benzene toxicity. Environ. Health Perspect. 100, 293−306
- Bratton S. B., 1997, Identification of quinol-thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol. 10, 859−865
- Thompson C. B., 1995, Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456−1462
- Moran J. L., 1996, Induction of apoptosis by benzene metabolites in HL-60 cells and CD34+ human bone marrow progenitor cells. Mol. Pharmacol. 50, 610−615
- Hazel B. A., 1996, Hydroquinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts. Stem Cells 14, 730−742
- Liu B., 1997, J. Biol. Chem., 272
- Hannun Y. A., 1996, Functions of ceramide in coordinating cellular responses to stress. Science 274
- Zager R. A., 1997, Kidney Int., 52, 70
- Nicholson D. W., 1995, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 376, 37−43
- Dobrowski R. T., 1992, J. Biol. Chem., 267
- Suzuki Y. J., 1997, Oxidants as stimulators of signal transduction. Free Radical Biol. Med. 22, 269−285
- Rajavashisth T. B., 1990, Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344, 254−257
- Ishiguro S., 1976, Glass capillary column gas chromatographic analysis of tobacco and cellulose cigarette smoke. I. Acidic fractions. Kenkyu HokokuNippon Senbai Kosha Chuo Kenkyusho 118, 207−211
- Kari F. W., 1992, Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. Food Chem. Toxicol. 30, 737−747
- Shibata M. A., 1991, Jpn. J. Cancer Res., 82
- Peters M. M., 1997, Cytotoxicity and cell proliferation induced by the nephrocarcinogen hydroquinone, and its nephrotoxic metabolite 2,3,5-tris-(glutathion-S-yl)hydroquinone. Carcinogenesis 18, 2393−2401
- Lau S. S., 2000, The nephrocarcinogenicity of a nephrotoxic metabolite of the “non-genotoxic
- Peters M. M., 1996, Metabolism of 2-tert-butylhydroquinone to S-substituted conjugates in the male Fischer 344 rat. Chem. Res. Toxicol. 9, 133−139
- Peters M. M., 1996, Glutathione conjugates of 2-tert-butylhydroquinone, metabolites of the renal tumor promoter tert-butylhydroxyanisole, are toxic to kidney and bladder. Cancer Res. 56, 1006−1011
- Tsuda H., 1984, Acta Pharmacol. Toxicol., Suppl., 2
- Ito N., 1986, Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis. Food Chem. Toxicol. 24, 1071−1082
- Verhagen H., 1989, Disposition of single oral doses of butylated hydroxyansiole in man and rat. Food Chem. Toxicol. 27, 151−158
- Shibata M. A., 1991, Toxicol. Lett., 55
- Verhagen H., 1991, Butylated hydroxyanisole in perspective. Chem.-Biol. Interact. 80, 109−134
- Liehr J. G., 1990, Free radical generation of cycling estrogens. Free Radical Biol. Med. 8, 415−423
- Matthews V. S., 1947, Proc. Soc. Exp. Biol. Med. 66
- Kirkman H., 1952, J. Natl. Cancer Inst., 13
- Kirkman H., 1959, Natl. Cancer Inst. Monogr., 1, 57
- Hattori N., 1991, II, III, and IV of mitochondria in Parkinson's disease. Ann. Neurol. 30, 563−571.
- Mizuno Y., 1994, An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35, 204−210
- Ikebe S., 1995, Point mutations of mitochondrial genome in Parkinson's disease. Brain Res. Mol. Brain Res. 28, 281−295
- Swerdlow R. H., 1996, Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663−671
- Kobayashi T., 1998, Association between the gene encoding the E2 subunit of the α-ketoglutarate dehydrogenase complex and Parkinson's disease. Ann. Neurol. 43, 120−123
- Schapira A. H. V., 1996, Neurodegeneration and Neuroprotection in Parkinson's Disease
- Dexter D. T., 1989, J. Neurochem., 52
- Alam Z. I., 1997, J. Neurochem., 69
- Alam Z. I., 1997, J. Neurochem., 69
- Benzi G., 1991, Sequential damage in mitochondrial complexes by peroxidative stress. Neurochem. Res. 16, 1295−1302
- Dexter D. T., 1994, Ann. Neurol., 35, 44
- Sian J., 1994, Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348−355
- Sian J., 1994, Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36, 356−361
- Seaton T. A., 1996, Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat. Biochem. Pharmacol. 52, 1657−1663
- Meister A., 1981, γ-Glutamyl transpeptidase. Methods Enzymol. 77, 237−253
- Mithofer K., 1992, Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes. Arch. Biochem. Biophys. 295, 132−136
- Khan S., 1997, Rapid and specific efflux of glutathione before hepatocyte injury induced by hypoxia. Biochem. Biophys. Res. Commun. 238, 320−322
- Reed D. J., 1995, Biochim. Biophys. Acta, 1271, 50
- Sanchez-Ramos J., 1998, Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures. Exp. Neurol. 150, 263−271
- Seidler A., 1996, Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 46, 1275−1284
- Fleming L., 1994, Parkinson's disease and brain levels of organochlorine pesticides. Ann. Neurol. 36, 100−103
- Corrigan F. M., 1998, Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp. Neurol. 150, 339−342
- Le Couteur D. G., 1998, The ageing liver: drug clearance and an oxygen diffusion barrier hypothesis. Clin. Pharmacokinet. 34, 359−373
- Ho S. L., 1996, Adv. Neurol., 69, 60
- Steventon G. B., 1989, Xenobiotic metabolism in Parkinson's disease. Neurology 39, 883−887
- Armstrong M., 1992, Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339, 1017−1018
- Stroombergen M. C., 1999, Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum. Exp. Toxicol. 18, 141−145
- De Palma G., 1998, Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet 352
- Bandmann O., 1997, Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 350, 1136−1139
- Shahi G. S., 1990, Parkinson's disease and cytochrome P450: a possible link? Med. Hypotheses 32, 277−282
- Gerlach M., 1996, J. Neural Transm., 103
- Ferraro T. N., 1986, Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse. Neuropharmacology 25, 1071−1074
- Yong V. W., 1986, Neurosci. Lett., 63, 60
- Oishi T., 1993, Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. J. Neural Transm.: Parkinson's Dis. Dementia Sect. 6, 45−52
- Ramsay R. R., 1986, Energy driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. Life Sci. 39, 581−588
- Mizuno Y., 1987, Inhibition of mitochondrial α-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion. Biochem. Biophys. Res. Commun. 143, 971−976
- Smith T. S., 1994, eport 5, 2598−2600.
- Cao C. J., 1990, ATP-regulated neuronal catecholamine uptake: a new mechanism. Life Sci. 47, 655−667
- Han J., 1999, J. Neurochem., 73
- Dringen R., 1997, The γ-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem. Res. 22, 727−733
- Novelli A., 1988, Glutamate becomes neurotoxic when intracellular energy levels are reduced. Brain Res. 451, 205−212
- Zeevalk G. D., 1991, J. Pharmacol. Exp. Ther., 257
- Olney J. W., 1990, l-Cysteine, a bicarbonate-sensitive excitotoxin. Science 248, 596−599
- Lafon-Cazal M., 1993, NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535−537
- Beal M. F., 1996, Neurodegeneration and Neuroprotection in Parkinson's Disease
- Beckman J. S., 1990, Proc. Natl. Acad. Sci. U.S.A. 87
- Flint D. H., 1993, J. Biol. Chem., 268
- Gutteridge J. M. C., 1996, Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann. N.Y. Acad. Sci. 738, 201−213
- Spencer J. P. E., 1998, J. Neurochem., 71
- Sagara J., 1993, J. Neurochem., 61
- Tate S. S., 1985, γ-Glutamyl transpeptidase from kidney. Methods Enzymol. 113, 400−437
- Zhang F., 1994, J. Med. Chem., 37
- Shen X.-M., 1996, Further insights into the influence of l-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease. Chem. Res. Toxicol. 9, 751−763
- Li H., 1997, J. Neurochem., 69
200 of 203 shown
Cited by
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
“Chemical agents like quinones (33); heavy metals such as lead, arsenic, mercury, chromium, and cadmium; organic solvents; and pesticides are common exogenous sources of ROS (331).”
BackgroundReview on in vivo and in vitro methods evaluation of antioxidant activity
Alam, M. N., Bristi, N. J., & Rafiquzzaman, M. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.05.002 · Cited by 1,758
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
VALAVANIDIS, A., FIOTAKIS, K., & VLACHOGIANNI, T. (2008) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590500802494538 · Cited by 1,491
Metadata
- Authors
- Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-02-23
- Volume
- 13
- Issue
- 3
- Pages
- 135-160
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2090990681
- Cited by
- 1,703
- References
- 96
- Citations by year
- 2026: 61 · 2025: 55 · 2024: 51 · 2023: 66 · 2022: 65 · 2021: 82 · 2020: 68 · 2019: 76 · 2018: 71 · 2017: 63 · 2016: 75 · 2015: 80 · 2014: 89 · 2013: 79 · 2012: 78
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Research in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01es003760-16)
- National Cancer Institute (CA73638)
- National Institute of Environmental Health Sciences (ES03760, ES03819, P30ES003819)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- quinones, quinone toxicity, Michael acceptors, alkylation, redox cycling, semiquinone, reactive oxygen species, oxidative stress, 8-hydroxy-2'-deoxyguanosine, carcinogenesis, immunotoxicity, cytotoxicity, benzene, polycyclic aromatic hydrocarbons, estrogen metabolites, catecholamines, protein kinase C, Ras signaling
- MeSH terms
- Alkylation, Animals, Benzene, Catecholamines, Estrogens, Humans, Polycyclic Aromatic Hydrocarbons, Quinones, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.